Editor's note: Ortho-McNeil Neurologics, Inc., announced on April 11, 2005, that its brand name Reminyl (galantamine hydrobromide) would be changed to Razadyne in response to FDA reports of ...

Johnson & Johnson has added a new warning to the label of its Alzheimer’s treatment, Reminyl, about two studies that included the deaths of 13 patients who took the drug and one who took a placebo, ...

WASHINGTON (MarketWatch) -- Johnson & Johnson said Friday that it is dropping a secondary study of its Alzheimer's drug Reminyl after two clinical trials showed people using the drug had a higher ...

> Aastrom's share were up on news that the FDA has lifted a clinical hold on the company's Phase II congestive heart failure trial. The trial is testing cardiac repair cells (CRC), which contain stem ...

The Institute for Safe Medication Practices (ISMP) had several reports of mix-ups in which the antidiabetic agent AMARYL (glimepiride) had been dispensed to geriatric patients instead of the Alzheimer ...

NEW YORK (Reuters Health) - Treatment with the Alzheimer's drug galantamine (Shire Pharmaceutical's Reminyl) reduces repetitive verbalization by people with Alzheimer's disease, according to a new ...